Is this your company? The full strategic profile database — relevance scoring against NATO/EU priorities, technologies and programmes — is
DFM Intelligence →EU research grants
| Project | Role | Programme | EC contribution |
|---|
| Myopia control in the real world: treatments, target, timing, and termin |
coordinator |
ERC-2022-ADG |
€2,500,000 |
| Revolutionary high-resolution human 3D brain organoid platform integrati |
coordinator |
HORIZON-EIC-2022-PATHFINDEROPEN-01 |
€1,133,750 |
| Ecology and biology of HPAIV H5 (Kappa-Flu) |
participant |
HORIZON-CL6-2022-FARM2FORK-02-two-stage |
€1,050,000 |
| B-specific: B-cell related gene and protein markers with prognostic and |
participant |
HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 |
€799,998 |
| Beyond COVID |
participant |
HORIZON-INFRA-2021-EMERGENCY-01 |
€794,853 |
| Infectious Disease decision-support tools and Alert systems to build cli |
participant |
HORIZON-HLTH-2021-ENVHLTH-02 |
€730,108 |
| New Prime Editing and non-viral delivery strategies for Gene Therapy |
participant |
HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 |
€727,210 |
| Insight into Drug Distribution and Local Concentration using Multispectr |
participant |
HORIZON-EIC-2021-PATHFINDEROPEN-01 |
€592,954 |
| Low and very-low-field 3D magnetic resonance spirometry for advanced reg |
participant |
HORIZON-EIC-2022-PATHFINDEROPEN-01 |
€516,013 |
| Artificial Right-Heart without External Power from Bench-to-Bedside |
participant |
HORIZON-EIC-2024-TRANSITION-01 |
€510,003 |
| Joint Understanding and Analysis of clade I monkeypox epidemiology, evol |
coordinator |
HORIZON-JU-GH-EDCTP3-2024-Mpox |
€325,000 |
| Management of avian influenza in a vaccination context |
participant |
HORIZON-MSCA-2023-DN-01 |
€274,370 |
| Physiological Role of Nonsense-Mediated Decay in Herpes Simplex Virus In |
coordinator |
HORIZON-MSCA-2021-PF-01 |
€203,464 |
| Visually Impaired children and adolescents: bridging the gap with Person |
participant |
HORIZON-HLTH-2024-STAYHLTH-01-two-stage |
€115,682 |
| Nanoplatforms and Oncolytic viruses for novel cancer immunotherapy stra |
participant |
HORIZON-MSCA-2024-DN-01 |
€0 |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Award data is official TED; payment and subscription happen on DFM Analysis.